Actively Recruiting
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
Led by Andrei Iagaru · Updated on 2025-09-10
100
Participants Needed
1
Research Sites
196 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study proposes the use of a well-established PET isotope, Fluorine-18 (18F), bound to Choline, for a prospective single-center, single-arm study for participants with suspected parathyroid adenoma and negative or equivocal standard of care 99mTc Sestamibi SPECT/CT
CONDITIONS
Official Title
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspected parathyroid adenoma with elevated serum calcium and inappropriately normal or high parathyroid hormone levels
- Negative or equivocal 99mTc Sestamibi SPECT/CT scan
- Able to provide written consent
- Total bilirubin less than or equal to 1.5 times the upper limit of normal
- Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) less than or equal to 5 times the upper limit of normal
- Karnofsky performance status greater than 50 or equivalent ECOG/WHO score
- Women must not be pregnant according to radiology policy
You will not qualify if you...
- Younger than 18 years at the time of radiotracer administration
- Creatinine clearance less than 60 mL/min or serum creatinine greater than 1.5 times the upper limit of normal
- QTcF interval greater than 470 msec on ECG or congenital long QT syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford Hospital and Clinics
Stanford, California, United States, 94305
Actively Recruiting
Research Team
A
Andrea Otte, DPT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here